how do strategics view retina opportunities? (ois@asrs 2016)
Published 8 years ago • 162 plays • Length 29:00Download video MP4
Download video MP3
Similar videos
-
17:24
where will imaging take retina treatments? (ois@asrs 2016)
-
22:20
retina experts serve up a combination platter at ois@asrs (ois@asrs 2016)
-
7:45
opthea: targeting a more complete blockade of vegf (ois@asrs 2016)
-
6:56
ocular therapeutix: intravitreal depot technology for retinal drug delivery (ois@asrs 2016)
-
41:58
ois podcast episode #302:finding and funding assets in retina, from ois retina@asrs
-
7:59
welcome to ois@asrs 2016
-
6:39
bioptigen driving intrasurgical oct use (ois@asrs 2016)
-
10:20
duker speaks to cost concerns, other challenges facing retina (ois@asrs - 2016)
-
38:46
ois podcast ep #404: the future of vision technology
-
28:31
ois podcast ep #386: quick takes from ophthalmology start-ups
-
31:26
reverse pitch by strategics
-
8:06
ois co chair bill link wraps up ois@asrs (ois@asrs 2016)
-
9:10
guerard: ophthalmology important to novartis (ois@asrs 2016)
-
12:28
saxton looks for early stage opportunities (ois@asrs - 2016)
-
5:44
re-vana therapeutics presentation on retinal drug delivery solutions at ois@asrs 2019
-
8:04
aerpio therapeutics: focus on tie2 activation (ois@asrs 2016)
-
4:57
tracery ophthalmics presentation on groundbreaking developments in ai & imaging at ois@asrs 2019
-
17:17
what were the highlights of ois@asrs?
-
13:03
vince anido, phd of aerie pharmaceuticals discusses new product lines at ois@asrs 2019
-
6:28
graybug vision presentation on retinal drug delivery solutions at ois@asrs 2019
-
9:52
artificial intelligence & ophthalmology interview with genentech's dr. ferrara at ois@asrs 2019